Centre d'Information et de documentation du CRA Rhône-Alpes
CRA
Informations pratiques
-
Adresse
Centre d'information et de documentation
du CRA Rhône-Alpes
Centre Hospitalier le Vinatier
bât 211
95, Bd Pinel
69678 Bron CedexHoraires
Lundi au Vendredi
9h00-12h00 13h30-16h00Contact
Tél: +33(0)4 37 91 54 65
Mail
Fax: +33(0)4 37 91 54 37
-
Détail de l'auteur
Auteur Genevieve GRIVAS |
Documents disponibles écrits par cet auteur (2)
Faire une suggestion Affiner la recherche
Classification of autism spectrum disorder from blood metabolites: Robustness to the presence of co-occurring conditions / Troy VARGASON in Research in Autism Spectrum Disorders, 77 (September 2020)
[article]
Titre : Classification of autism spectrum disorder from blood metabolites: Robustness to the presence of co-occurring conditions Type de document : Texte imprimé et/ou numérique Auteurs : Troy VARGASON, Auteur ; Emily ROTH, Auteur ; Genevieve GRIVAS, Auteur ; Jennifer FERINA, Auteur ; Richard E. FRYE, Auteur ; Juergen HAHN, Auteur Article en page(s) : 101644 Langues : Anglais (eng) Mots-clés : Autism spectrum disorder Co-occurring conditions Folate-dependent one-carbon metabolism Transsulfuration Multivariate analysis Classification Index. décimale : PER Périodiques Résumé : Background Previous studies have found plasma measurements of metabolites from the folate-dependent one-carbon metabolism (FOCM) and transsulfuration (TS) pathways to be useful for differentiating individuals with autism spectrum disorder (ASD) from their typically developing peers. However, ASD is heterogeneous due to wide variation in the presence of co-occurring behavioral and medical conditions, and it is unknown how these conditions influence the ability to identify ASD based on FOCM/TS metabolites. Method This study employs a previously developed multivariate model that makes use of five FOCM/TS measurements (S-adenosylmethionine/S-adenosylhomocysteine, glutamylcysteine, glutathione disulfide, free cystine/free cysteine, and percent oxidized glutathione) to distinguish children with ASD from typically developing children. The model is used here to evaluate an independent cohort of individuals having ASD with diagnosed co-occurring conditions (age range 2–17 years old) and assess classifier performance in the presence/absence of these conditions. The four categories of co-occurring conditions considered were allergic disorders, gastrointestinal disorders, immune/metabolic disorders, and neurological disorders. All data were collected and retrospectively analyzed from previous clinical studies. Results The model was able to identify 124 of 131 participants with ASD (94.7 %) correctly regardless of co-occurring condition status. Model performance was generally not sensitive to the absence or presence of most co-occurring conditions, with the exceptions of ever/never having allergies or gastrointestinal symptoms, or currently (not) having any condition, all of which had minor impacts on model prediction accuracy. Conclusion The results of this exploratory study suggest that a FOCM/TS-based classifier for diagnosing ASD may potentially be robust to variations in co-occurring conditions and potentially applicable across ASD subtypes. Larger, more comprehensive follow-up studies with typically developing and/or developmentally delayed control groups are required to provide a more conclusive assessment of classifier robustness to co-occurring conditions. En ligne : https://doi.org/10.1016/j.rasd.2020.101644 Permalink : https://www.cra-rhone-alpes.org/cid/opac_css/index.php?lvl=notice_display&id=432
in Research in Autism Spectrum Disorders > 77 (September 2020) . - 101644[article] Classification of autism spectrum disorder from blood metabolites: Robustness to the presence of co-occurring conditions [Texte imprimé et/ou numérique] / Troy VARGASON, Auteur ; Emily ROTH, Auteur ; Genevieve GRIVAS, Auteur ; Jennifer FERINA, Auteur ; Richard E. FRYE, Auteur ; Juergen HAHN, Auteur . - 101644.
Langues : Anglais (eng)
in Research in Autism Spectrum Disorders > 77 (September 2020) . - 101644
Mots-clés : Autism spectrum disorder Co-occurring conditions Folate-dependent one-carbon metabolism Transsulfuration Multivariate analysis Classification Index. décimale : PER Périodiques Résumé : Background Previous studies have found plasma measurements of metabolites from the folate-dependent one-carbon metabolism (FOCM) and transsulfuration (TS) pathways to be useful for differentiating individuals with autism spectrum disorder (ASD) from their typically developing peers. However, ASD is heterogeneous due to wide variation in the presence of co-occurring behavioral and medical conditions, and it is unknown how these conditions influence the ability to identify ASD based on FOCM/TS metabolites. Method This study employs a previously developed multivariate model that makes use of five FOCM/TS measurements (S-adenosylmethionine/S-adenosylhomocysteine, glutamylcysteine, glutathione disulfide, free cystine/free cysteine, and percent oxidized glutathione) to distinguish children with ASD from typically developing children. The model is used here to evaluate an independent cohort of individuals having ASD with diagnosed co-occurring conditions (age range 2–17 years old) and assess classifier performance in the presence/absence of these conditions. The four categories of co-occurring conditions considered were allergic disorders, gastrointestinal disorders, immune/metabolic disorders, and neurological disorders. All data were collected and retrospectively analyzed from previous clinical studies. Results The model was able to identify 124 of 131 participants with ASD (94.7 %) correctly regardless of co-occurring condition status. Model performance was generally not sensitive to the absence or presence of most co-occurring conditions, with the exceptions of ever/never having allergies or gastrointestinal symptoms, or currently (not) having any condition, all of which had minor impacts on model prediction accuracy. Conclusion The results of this exploratory study suggest that a FOCM/TS-based classifier for diagnosing ASD may potentially be robust to variations in co-occurring conditions and potentially applicable across ASD subtypes. Larger, more comprehensive follow-up studies with typically developing and/or developmentally delayed control groups are required to provide a more conclusive assessment of classifier robustness to co-occurring conditions. En ligne : https://doi.org/10.1016/j.rasd.2020.101644 Permalink : https://www.cra-rhone-alpes.org/cid/opac_css/index.php?lvl=notice_display&id=432 Maternal risk factors vary between subpopulations of children with autism spectrum disorder / Genevieve GRIVAS in Autism Research, 15-11 (November 2022)
[article]
Titre : Maternal risk factors vary between subpopulations of children with autism spectrum disorder Type de document : Texte imprimé et/ou numérique Auteurs : Genevieve GRIVAS, Auteur ; Richard E. FRYE, Auteur ; Juergen HAHN, Auteur Article en page(s) : p.2038-2055 Langues : Anglais (eng) Mots-clés : Child Pregnancy Female Humans Autism Spectrum Disorder/complications/epidemiology/diagnosis Case-Control Studies Pregnancy Complications Risk Factors Immune System Diseases/complications Seizures/complications associated risk autism spectrum disorder co-occurring conditions logistic regression medical claims retrospective analysis subgroups Index. décimale : PER Périodiques Résumé : Previous work identified three subgroups of children with ASD based upon co-occurring conditions (COCs) diagnosed during the first 5 years of life. This work examines prenatal risk factors, given by maternal medical claims, for each of the three subgroups: children with a High-Prevalence of COCs, children with mainly developmental delay and seizures (DD/Seizure COCs), and children with a Low-Prevalence of COCs. While some risk factors are shared by all three subgroups, the majority of the factors identified for each subgroup were unique; infections, anti-inflammatory and other complex medications were associated with the High-Prevalence COCs group; immune deregulatory conditions such as asthma and joint disorders were associated with the DD/Seizure COCs group; and overall pregnancy complications were associated with the Low-Prevalence COCs group. Thus, we have found that the previously identified subgroups of children with ASD have distinct associated prenatal risk factors. As such, this work supports subgrouping children with ASD based upon COCs, which may provide a framework for elucidating some of the heterogeneity associated with ASD. En ligne : http://dx.doi.org/10.1002/aur.2809 Permalink : https://www.cra-rhone-alpes.org/cid/opac_css/index.php?lvl=notice_display&id=488
in Autism Research > 15-11 (November 2022) . - p.2038-2055[article] Maternal risk factors vary between subpopulations of children with autism spectrum disorder [Texte imprimé et/ou numérique] / Genevieve GRIVAS, Auteur ; Richard E. FRYE, Auteur ; Juergen HAHN, Auteur . - p.2038-2055.
Langues : Anglais (eng)
in Autism Research > 15-11 (November 2022) . - p.2038-2055
Mots-clés : Child Pregnancy Female Humans Autism Spectrum Disorder/complications/epidemiology/diagnosis Case-Control Studies Pregnancy Complications Risk Factors Immune System Diseases/complications Seizures/complications associated risk autism spectrum disorder co-occurring conditions logistic regression medical claims retrospective analysis subgroups Index. décimale : PER Périodiques Résumé : Previous work identified three subgroups of children with ASD based upon co-occurring conditions (COCs) diagnosed during the first 5 years of life. This work examines prenatal risk factors, given by maternal medical claims, for each of the three subgroups: children with a High-Prevalence of COCs, children with mainly developmental delay and seizures (DD/Seizure COCs), and children with a Low-Prevalence of COCs. While some risk factors are shared by all three subgroups, the majority of the factors identified for each subgroup were unique; infections, anti-inflammatory and other complex medications were associated with the High-Prevalence COCs group; immune deregulatory conditions such as asthma and joint disorders were associated with the DD/Seizure COCs group; and overall pregnancy complications were associated with the Low-Prevalence COCs group. Thus, we have found that the previously identified subgroups of children with ASD have distinct associated prenatal risk factors. As such, this work supports subgrouping children with ASD based upon COCs, which may provide a framework for elucidating some of the heterogeneity associated with ASD. En ligne : http://dx.doi.org/10.1002/aur.2809 Permalink : https://www.cra-rhone-alpes.org/cid/opac_css/index.php?lvl=notice_display&id=488